212 related articles for article (PubMed ID: 19131186)
41. Retrospective analysis of relapsed or primary refractory childhood lymphoblastic lymphoma in Japan.
Mitsui T; Mori T; Fujita N; Inada H; Horibe K; Tsurusawa M;
Pediatr Blood Cancer; 2009 May; 52(5):591-5. PubMed ID: 19156862
[TBL] [Abstract][Full Text] [Related]
42. [Treatment of Hodgkin's disease by segmental radiotherapy extended above and below the diaphragm].
Kahn A; Laugier A; Zittoun R; Bernadou A; Bilski-Pasquier G; Bousser J
Ann Med Interne (Paris); 1972 Dec; 123(12):1005-18. PubMed ID: 4664535
[No Abstract] [Full Text] [Related]
43. Treatment of refractory Hodgkin's lymphoma patients with an iodine-131-labeled murine anti-CD30 monoclonal antibody.
Schnell R; Dietlein M; Staak JO; Borchmann P; Schomaecker K; Fischer T; Eschner W; Hansen H; Morschhauser F; Schicha H; Diehl V; Raubitschek A; Engert A
J Clin Oncol; 2005 Jul; 23(21):4669-78. PubMed ID: 16034043
[TBL] [Abstract][Full Text] [Related]
44. Very late relapse of Hodgkin's disease after 24 years of complete remission.
Dimopoulos MA; Kostis E; Anagnostopoulos A; Dalezios M; Papadimitris C; Papadimitriou C
Leuk Lymphoma; 1997 Dec; 28(1-2):215-7. PubMed ID: 9498723
[TBL] [Abstract][Full Text] [Related]
45. Extended-field radiotherapy in the treatment of Hodgkin's disease.
Tepmongkol P
J Med Assoc Thai; 1982 Feb; 65(2):55-62. PubMed ID: 7077213
[No Abstract] [Full Text] [Related]
46. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience.
Tham IW; Hee SW; Yeo RM; Salleh PB; Lee J; Tan TW; Fong KW; Chua ET; Wee JT
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1481-6. PubMed ID: 19386431
[TBL] [Abstract][Full Text] [Related]
47. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
Callera F; Cavenaghi L; de Melo CM
Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
[TBL] [Abstract][Full Text] [Related]
48. Late relapse of Hodgkin's disease after 25 years.
Ibrahim EM
Indian J Cancer; 1990 Mar; 27(1):17-9. PubMed ID: 2391126
[TBL] [Abstract][Full Text] [Related]
49. Prolonged survival after liver transplantation for Hodgkin's disease-induced fulminant liver failure.
Abdulkader I; Fraga M; González-Quintela A; Caparrini A; Bello JL; Galbán C; Varo E; Diaz-Mediavilla J; Forteza J
Hepatogastroenterology; 2005; 52(61):217-9. PubMed ID: 15783034
[TBL] [Abstract][Full Text] [Related]
50. More than a third of non-gastric malt lymphomas are disseminated at diagnosis: a single center survey.
Sretenovic M; Colovic M; Jankovic G; Suvajdzic N; Mihaljevic B; Colovic N; Todorovic M; Atkinson HD
Eur J Haematol; 2009 May; 82(5):373-80. PubMed ID: 19141118
[TBL] [Abstract][Full Text] [Related]
51. The treatment of childhood Hodgkin lymphoma: improved survival in a developing country.
Büyükpamukçu M; Varan A; Akyüz C; Atahan L; Ozyar E; Kale G; Köksal Y; Kutluk T
Acta Oncol; 2009; 48(1):44-51. PubMed ID: 18777215
[TBL] [Abstract][Full Text] [Related]
52. Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma.
Advani R; Forero-Torres A; Furman RR; Rosenblatt JD; Younes A; Ren H; Harrop K; Whiting N; Drachman JG
J Clin Oncol; 2009 Sep; 27(26):4371-7. PubMed ID: 19636010
[TBL] [Abstract][Full Text] [Related]
53. Nodular lymphocyte-predominant hodgkin lymphoma.
Tsai HK; Mauch PM
Semin Radiat Oncol; 2007 Jul; 17(3):184-9. PubMed ID: 17591565
[TBL] [Abstract][Full Text] [Related]
54. Hodgkin's disease: survival and relapse-free data.
Smithers DW
Natl Cancer Inst Monogr; 1973 May; 36():509-12. PubMed ID: 4744606
[No Abstract] [Full Text] [Related]
55. Radiotherapy of Langerhans' Cell Histiocytosis : Results and Implications of a National Patterns-of-Care Study.
Olschewski T; Seegenschmiedt MH
Strahlenther Onkol; 2006 Nov; 182(11):629-34. PubMed ID: 17072519
[TBL] [Abstract][Full Text] [Related]
56. Excellent local control from radiation therapy for high-risk neuroblastoma.
Gatcombe HG; Marcus RB; Katzenstein HM; Tighiouart M; Esiashvili N
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1549-54. PubMed ID: 19211198
[TBL] [Abstract][Full Text] [Related]
57. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
58. [The problem of restoring bone marrow, irradiated during radiotherapy of Hodgkin's disease patients].
Kanaev SV; Novikov SN
Vopr Onkol; 2001; 47(4):411-6. PubMed ID: 11710280
[TBL] [Abstract][Full Text] [Related]
59. Cutaneous Hodgkin's disease.
Introcaso CE; Kantor J; Porter DL; Junkins-Hopkins JM
J Am Acad Dermatol; 2008 Feb; 58(2):295-8. PubMed ID: 18222326
[TBL] [Abstract][Full Text] [Related]
60. Efficacy and feasibility of IDEA therapy for refractory or relapsed non-Hodgkin's lymphoma.
Nishimori H; Fujii N; Maeda Y; Matsuoka K; Takenaka K; Shinagawa K; Ikeda K; Matsuo K; Harada M; Tanimoto M
Anticancer Res; 2009 May; 29(5):1749-54. PubMed ID: 19443398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
